DRUG
#3014
Bright Minds Biosciences Inc. - common stock
51.3 6 USD
-0.05%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-4.91%
Monatliche Änderung
-17.03%
6 month change
-42.08%
Jahresänderung
-25.23%
Vorheriger Schlusskurs
54.0 1
Open
54.2 1
Tief
50.9 9
Hoch
54.3 5
Financials
- Market Capitalization 392.17 M
- Employee 25
- Founded 2017
- CEO N/A
- Website www.brightmindsbio.com
- Headquarter British Columbia, Canada
- FIGI BBG00ZKX9FP7
- Industry Biotechnologie
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 3002 |  CAPR Capricor Therapeutics, Inc. - Common Stock | 6.88 USD | -7.90% | -9.35% | -22.08% | +2.38% | 400.00 M USD | ||
| 3003 |  AVIR Atea Pharmaceuticals, Inc. - common stock | 4.98 USD | -0.99% | -0.80% | -6.04% | +55.14% | 399.42 M USD | ||
| 3048 |  EDIT Editas Medicine, Inc. - Common Stock | 2.45 USD | -10.91% | -9.59% | -8.92% | -33.42% | 376.27 M USD | ||
| 3057 |  GALT Galectin Therapeutics Inc. - Common Stock | 3.69 USD | -4.65% | -1.34% | -3.40% | -26.93% | 372.14 M USD |